Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines
- 25 June 2004
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 62 (2) , 187-199
Abstract
BACKGROUND The specific inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, ZD1839 induces potent antitumoral effects on several advanced cancer types. The present study was undertaken to determine whether the combination of ZD1839 with an agent donating nitric oxide (NO•), sodium nitroprusside (SNP) results in a synergy of anticarcinogenic responses on metastatic prostate cancer (PC) cells. METHODS The antiproliferative and apoptotic/necrotic effects of ZD1839 and SNP alone or in combination were estimated on EGF- and serum-stimulated LNCaP, DU145, and PC3 cells by MTT growth tests, trypan blue dye exclusion method, and flow cytometric analyses. Moreover, the cellular ceramide levels were evaluated by the diacylglycerol kinase enzymatic method and the amounts of cytosolic cytochrome c by ELISA assays. RESULTS ZD1839 and SNP alone or in combination at lower concentrations induced an inhibition of EGF- and serum-stimulated growth of LNCaP, DU145, and PC3 concomitant with an arrest in the G1 phase of cellular cycle. Interestingly, the mixed ZD1839 and SNP also caused a more substantial apoptotic/necrotic death of these PC cells as compared to drugs alone. Moreover, we have observed that an inhibition of acidic sphingomyelinase, hydrogen peroxide (H2O2) accumulation and caspase cascades results in a significant reduction of apoptotic/necrotic death induced by mixed ZD1839 and SNP in EGF-stimulated PC3 cells. In addition, the combined ZD1839 plus SNP also induced a higher cellular ceramide and reactive oxygen species (ROS) production, mitochondrial transmembrane potential decrease, and cytochrome c amount released into cytosol as compared to drugs alone. CONCLUSIONS The simultaneous use of EGFR inhibitor and compound releasing NO• might lead to a synergy in the ceramide and ROS production which might cause cellular membrane damages resulting in a massive apoptotic/necrotic death of metastatic PC cells.Keywords
Funding Information
- Ligue Contre le Cancer
This publication has 59 references indexed in Scilit:
- ZD1839: targeting the epidermal growth factor receptor in cancer therapyExpert Opinion on Investigational Drugs, 2002
- Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitorThe Prostate, 2002
- Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosisBiochemical and Biophysical Research Communications, 2002
- Cross-talk between nitric oxide and superoxide determines ceramide formation and apoptosis in glomerular cellsKidney International, 2002
- The role of α6β1 integrin and EGF in normal and malignant acinar morphogenesis of human prostatic epithelial cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2001
- GROWTH FACTORS: ROLES IN ANDROLOGYArchives of Andrology, 2001
- Biochemical Characterization of Extracellular cAMP-Dependent Protein Kinase as a Tumor MarkerBiochemical and Biophysical Research Communications, 2000
- Sphingomyelin Potentiates Chemotherapy of Human Cancer XenograftsBiochemical and Biophysical Research Communications, 2000
- Nitric Oxide Stimulates Chronic Ceramide Formation in Glomerular Endothelial CellsBiochemical and Biophysical Research Communications, 1999
- Differential Regulation of Sphingomyelinase and Ceramidase Activities by Growth Factors and CytokinesJournal of Biological Chemistry, 1995